A detailed history of Cibc Private Wealth Group, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,000 shares of AVXL stock, worth $15,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$15,580
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$4.55 - $6.75 $9,100 - $13,500
2,000 New
2,000 $10,000
Q3 2018

Nov 14, 2018

SELL
$2.23 - $3.82 $278 - $477
-125 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$3.12 - $4.94 $390 - $617
125
125 $0

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $607M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.